XML 25 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 6,266 $ 6,037
Marketable securities 4,381 2,874
Trade receivables, net 4,525 4,057
Inventories 3,893 3,584
Other current assets 2,079 1,888
Total current assets 21,144 18,440
Property, plant and equipment, net 4,889 4,928
Intangible assets, net 16,587 19,413
Goodwill 14,689 14,703
Other assets 5,639 2,223
Total assets 62,948 59,707
Current liabilities:    
Accounts payable 1,421 1,371
Accrued liabilities 10,141 8,511
Current portion of long-term debt 91 2,953
Total current liabilities 11,653 12,835
Long-term debt 32,895 26,950
Long-term tax liabilities 6,968 8,037
Other noncurrent liabilities 2,023 2,212
Contingencies and commitments
Common Stock, Shares Authorized 2,750.0 2,750.0
Common Stock, Shares, Outstanding 578.3 591.4
Common Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Stockholders’ equity:    
Common stock and additional paid-in capital; $0.0001 par value per share; 2,750.0 shares authorized; outstanding— 578.3 shares in 2020 and 591.4 shares in 2019 $ 31,802 $ 31,531
Accumulated deficit (21,408) (21,330)
Accumulated other comprehensive loss (985) (528)
Total stockholders’ equity 9,409 9,673
Total liabilities and stockholders’ equity $ 62,948 $ 59,707